Point72 Europe (London) LLP Twist Bioscience Corp Transaction History
Point72 Europe (London) LLP
- $1.97 Billion
- Q3 2025
A detailed history of Point72 Europe (London) LLP transactions in Twist Bioscience Corp stock. As of the latest transaction made, Point72 Europe (London) LLP holds 1,717 shares of TWST stock, worth $46,135. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,717Holding current value
$46,135% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TWST
# of Institutions
264Shares Held
74.4MCall Options Held
150KPut Options Held
81.1K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.73MShares$181 Million1.33% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.41MShares$172 Million0.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.77MShares$155 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.42MShares$146 Million0.01% of portfolio
-
William Blair Investment Management, LLC Chicago, IL4.14MShares$111 Million0.33% of portfolio
About Twist Bioscience Corp
- Ticker TWST
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 56,363,500
- Market Cap $1.51B
- Description
- Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...